AI Market Mood: Stock Dashboard
ZBIO
Fundamental
Company: Zenas Biopharma Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: Small
Index: RUT
P/E: -
EPS (ttm): -8.44
Insider Own: 54.85%
Shs Outstand: 54.49M
Perf Week: 18.69%
Market Cap: 1.19B
Forward P/E: -
EPS next Y: -4.61
Insider Trans: 1.76%
Shs Float: 25.90M
Perf Month: -7.34%
Enterprise Value: 931.61M
PEG: -
EPS next Q: -1.47
Inst Own: 43.59%
Short Float: 39.47%
Perf Quarter: 0.82%
Income: -377.74M
P/S: 119.48
EPS this Y: 42.83%
Inst Trans: 13.21%
Short Ratio: 13.65
Perf Half Y: -33.51%
Sales: 10.00M
P/B: 4.69
EPS next Y Percentage: 4.53%
ROA: -100.25%
Short Interest: 10.22M
Perf YTD: -42.63%
Book/sh: 4.44
P/C: 3.48
EPS next 5Y: 22.85%
ROE: -136.22%
52W High: 44.60 -53.30%
Perf Year: 130.80%
Cash/sh: 5.98
P/FCF: -
EPS past 3/5Y: -39.47% -
ROIC: -117.68%
52W Low: 8.51 144.77%
Perf 3Y: -
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: - -
Gross Margin: 99.44%
Volatility W: 8.35%
Volatility M: 6.90%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 93.16
EPS Y/Y TTM: -116.54%
Oper. Margin: -2113.85%
ATR (14): 1.51
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 5.61
Sales Y/Y TTM: 100.00%
Profit Margin: -3777.37%
RSI (14): 51.67
Recom: 1.25
Dividend Gr. 3/5Y: - -
Current Ratio: 5.61
EPS Q/Q: -310.86%
SMA20: 3.43%
Beta: -0.58
Target Price: 42.00
Payout: -
Debt/Eq: 0.33
Sales Q/Q: -100.00%
SMA50: -5.27%
Rel Volume: 0.00
Prev Close: 20.83
Employees: 167
LT Debt/Eq: 0.33
Earnings: Mar 16 BMO
SMA200: -14.35%
Avg Volume: 749.03K
Price: 20.83
IPO: Sep 13, 2024
Option/Short: Yes / Yes
EPS/Sales Surpr.: -353.37% -100.00%
Trades:
Volume: 0
Change: 0.00%
Technical:
Latest News:
Bristol-Myers Squibb-backed Zenas BioPharma seeks up to $689.7 million valuation in US IPO somewhat bullish
ZBIO
Summary: Zenas BioPharma aims for a valuation of up to $689.7 million in its U.S. IPO, backed by Bristol-Myers Squibb and targeting to raise $211.7 million by offering 11.76 million shares.
Full article2024-09-06T12:28:43Z